Contact: Scott Young Vice President, Corporate Communications & Investor Relations Flexion Therapeutics, Inc. SHARE THIS POST Flexion Therapeutics NewsMORE your MARKET VIEW Related Stocks Find News …
More Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Videos